Q2 Earnings Estimate for ACHC Issued By Leerink Partnrs

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Stock analysts at Leerink Partnrs issued their Q2 2025 earnings estimates for shares of Acadia Healthcare in a note issued to investors on Wednesday, May 14th. Leerink Partnrs analyst W. Mayo anticipates that the company will post earnings per share of $0.61 for the quarter. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.38 per share. Leerink Partnrs also issued estimates for Acadia Healthcare’s Q3 2025 earnings at $0.78 EPS, Q4 2025 earnings at $0.79 EPS, Q1 2026 earnings at $0.49 EPS, Q2 2026 earnings at $0.72 EPS, Q3 2026 earnings at $0.87 EPS, FY2026 earnings at $2.91 EPS and FY2027 earnings at $3.32 EPS.

ACHC has been the topic of several other reports. Mizuho lowered their price objective on shares of Acadia Healthcare from $37.00 to $32.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 14th. KeyCorp lowered their target price on shares of Acadia Healthcare from $65.00 to $55.00 and set an “overweight” rating on the stock in a report on Wednesday, May 14th. Royal Bank of Canada lowered their target price on shares of Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating on the stock in a report on Monday, March 3rd. Bank of America lowered their target price on shares of Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating on the stock in a report on Friday, February 28th. Finally, Barclays lowered their target price on shares of Acadia Healthcare from $35.00 to $28.00 and set an “equal weight” rating on the stock in a report on Wednesday, May 14th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $47.94.

Acadia Healthcare Trading Down 4.1%

Shares of Acadia Healthcare stock opened at $25.08 on Monday. Acadia Healthcare has a 1 year low of $20.36 and a 1 year high of $82.41. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The company has a market capitalization of $2.31 billion, a P/E ratio of 8.22, a PEG ratio of 1.46 and a beta of 1.01. The company’s fifty day moving average is $26.12 and its two-hundred day moving average is $35.37.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.05. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The company had revenue of $770.51 million for the quarter, compared to the consensus estimate of $769.90 million. During the same period last year, the firm posted $0.84 EPS. Acadia Healthcare’s revenue for the quarter was up .3% on a year-over-year basis.

Institutional Trading of Acadia Healthcare

Hedge funds and other institutional investors have recently made changes to their positions in the stock. JPMorgan Chase & Co. lifted its stake in shares of Acadia Healthcare by 17.0% in the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock valued at $198,258,000 after purchasing an additional 454,044 shares during the period. SG Americas Securities LLC lifted its stake in shares of Acadia Healthcare by 713.3% in the fourth quarter. SG Americas Securities LLC now owns 110,866 shares of the company’s stock valued at $4,396,000 after purchasing an additional 97,235 shares during the period. Beach Point Capital Management LP acquired a new stake in shares of Acadia Healthcare in the fourth quarter valued at about $14,097,000. Sterling Capital Management LLC raised its position in Acadia Healthcare by 59.1% during the fourth quarter. Sterling Capital Management LLC now owns 5,456 shares of the company’s stock worth $216,000 after acquiring an additional 2,026 shares during the last quarter. Finally, Stephens Investment Management Group LLC raised its position in Acadia Healthcare by 24.9% during the fourth quarter. Stephens Investment Management Group LLC now owns 1,475,166 shares of the company’s stock worth $58,490,000 after acquiring an additional 294,210 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.